These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10533336)

  • 1. Pharmacogenomics: tailoring drug therapy.
    Langevin BC
    J Am Pharm Assoc (Wash); 1999; 39(5):597-8. PubMed ID: 10533336
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics: tailoring the drug to the patient.
    Zurlinden J
    Nurs Spectr (Wash D C); 1998 Jul; 8(15):10, 24. PubMed ID: 10542753
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years.
    Streetman DS
    Ann Pharmacother; 2007 Dec; 41(12):2038-41. PubMed ID: 17956958
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics and the future of drug therapy.
    Hines RN; McCarver DG
    Pediatr Clin North Am; 2006 Aug; 53(4):591-619. PubMed ID: 16872995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing race-based prescribing precision with pharmacogenomics.
    Nguyen A; Desta Z; Flockhart DA
    Clin Pharmacol Ther; 2007 Mar; 81(3):323-5. PubMed ID: 17339860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Welcome to Pharmacogenomics 2004 - pharmacogenomics comes of age.
    Lemmens N
    Pharmacogenomics; 2004 Jan; 5(1):I. PubMed ID: 14683413
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics: improving drug and dose selection.
    Bhathena A; Spear BB
    Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of pharmacogenomics for drug development and clinical practice.
    Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
    Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized pharmacotherapy: genotypes, biomarkers, and beyond.
    Gurwitz D; Lunshof JE
    Clin Pharmacol Ther; 2009 Feb; 85(2):142. PubMed ID: 19005463
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snipping away at human disease. Into the era of individually tailored therapies.
    Fischer J
    US News World Rep; 2000 Oct; 129(16):58-9. PubMed ID: 11184577
    [No Abstract]   [Full Text] [Related]  

  • 12. [New drugs are tested on virtual patients. It will be possible to test new drugs on virtual patients, existing only in a computer].
    Andreasen J
    Ugeskr Laeger; 2003 May; 165(19):1961-2. PubMed ID: 12795067
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead.
    Nebert DW; Vesell ES
    Eur J Pharmacol; 2004 Oct; 500(1-3):267-80. PubMed ID: 15464039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in pharmacogenomics and therapeutics.
    Kane MD; Summers KH
    J Manag Care Pharm; 2007 Sep; 13(7):607-8. PubMed ID: 17874867
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics: the promise of personalized medicine.
    Hood E
    Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics in the discovery and development of medicines.
    Roses AD
    Novartis Found Symp; 2000; 229():63-6; discussion 66-70. PubMed ID: 11084930
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in cancer chemotherapy: current strategies, pharmacokinetics, and pharmacogenomics.
    Nishiyama M; Eguchi H
    Adv Drug Deliv Rev; 2009 May; 61(5):367-8. PubMed ID: 19154764
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference Scene: Pharmacogenomics at the second PharmSciFair 2009: adverse drug reactions and clinical implementation.
    van Schie RM; Cascorbi I; Maitland-van der Zee AH
    Pharmacogenomics; 2009 Sep; 10(9):1389-91. PubMed ID: 19761363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacogenomics: way to individual therapy].
    Piruzian AL
    Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.